发明名称 |
NON-INVASIVE PRENATAL DIAGNOSIS OF FETAL GENETIC CONDITION USING CELLULAR DNA AND CELL FREE DNA |
摘要 |
Disclosed are methods for determining at least one sequence of interest of a fetus of a pregnant mother. In various embodiments, the method can determine one or more sequences of interest in a test sample that comprises a mixture of fetal cellular DNA and mother-and-fetus cfDNA. In some embodiments, methods are provided for determining whether the fetus has a genetic disease. In some embodiments, methods are provided for determining whether the fetus is homozygous in a disease causing allele when the mother is heterozygous of the same allele. In some embodiments, methods are provided for determining whether the fetus has a copy number variation (CNV) or a non-CNV genetic sequence anomaly. |
申请公布号 |
US2016186253(A1) |
申请公布日期 |
2016.06.30 |
申请号 |
US201514802873 |
申请日期 |
2015.07.17 |
申请人 |
Illumina, Inc. |
发明人 |
Talasaz AmirAli Hajhossein;Cann Gordon M. |
分类号 |
C12Q1/68;G06F19/22 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for determining at least one sequence of interest of a fetus of a pregnant mother, the method comprising:
(a) obtaining cellular DNA from the blood of the pregnant mother, wherein the cellular DNA comprises fetal cellular DNA; (b) obtaining mother-and-fetus mixed cfDNA from the blood of the pregnant mother; (c) applying an indicator to at least one of the fetal cellular DNA and the mixed cfDNA, wherein the indicator identifies a source of DNA as being from the fetal cellular DNA or the mixed cfDNA; (d) combining the fetal cellular DNA and the mixed cfDNA to provide a sample of combined cellular DNA and cfDNA; (e) sequencing the sample of combined cellular DNA and cfDNA to provide a plurality of sequence tags; and (f) analyzing the plurality of sequence tags to determine the presence and/or abundance of the at least one sequence of interest in the fetus's DNA, wherein at least a portion of the plurality of sequence tags map to the at least one sequence of interest. |
地址 |
San Diego CA US |